EGFR and non-small cell lung carcinoma: Approximately 85% of all lung cancers are non-small cell lung cancer (NSCLC) [2].In advanced non-small cell lung cancer (NSCLC), epidermal growth factor receptor (EGFR) mutations are presented in approximately 40% of Asian populations and approximately 10% to 15% in non-Asian populations [3, 4].